Prohibition Partners
Home / Cannabis Markets / Finland
Finland flag

Is cannabis legal in Finland?

Medical cannabis is legal in Finland and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.

Medical: LegalAdult-use: Illegal

Market size

Medical cannabis sales and registered patients in Finland, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Finland data pack.

Medical sales, EUR

€454k2025€497.9k2026€541.7k2027202820292030
Metric202520262027202820292030
Medical sales€454k€497.9k€541.7k
Patients310340370

Forecasts to 2030 — sales, patients and the full Finland series — are in the Finland data pack, or scoped to your question in a bespoke brief.

See the data pack Request a brief

Source: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)

Recently in Finland

From International Cannabis Weekly, our free global briefing.

Latest issue №467
  1. Finnish left alliance major party officially endorses adult cannabis legalisation and regulated distribution model.

    Newsweed · 431 · 19 Dec 2025 · Regulation

  2. Finland's Left Alliance supports legal cannabis sales through state-run shops

    helsinkitimes.fi · 428 · 28 Nov 2025 · Regulation

  3. Finnish citizens' initiative for cannabis legalisation surpasses 50,000 signatures

    336 · 9 Feb 2024 · Regulation

  4. More people in Finland say regular cannabis use not as risky as weekly binge drinking

    yle.fi · 295 · 21 Apr 2023 · Health & Science

  5. Finland Centre Party youth wing supports cannabis decriminalisation for medical use

    yle.fi · 247 · 13 May 2022 · Medical

  6. Finnish Greens party calls for cannabis legalisation

    BusinessCann · 215 · 17 Sept 2021 · Regulation

Medical cannabis — overview

Medical cannabis (flower & oil products) is an unlicensed medicine and is strictly controlled in Finland, requiring a special permit granted by the Finnish Medicines Agency (Fimea).

Doctors who are pain management specialists at university hospitals, as well as health centre doctors, can prescribe medical cannabis with a special permit application. To prescribe unlicensed medical cannabis products, doctors must justify that the patient has exhausted all other authorised medicines and that a prescription would be beneficial for treatment.

The treatable pathologies for which unlicensed medical cannabis products have been prescribed in Finland include multiple sclerosis, Parkinson’s disease, severe rheumatism, spinal cord injuries, fibromyalgia, and nervous and chronic pain.

The number of prescriptions of unlicensed medical cannabis products has dropped in Finland as health agencies have warned doctors off the prescription of Bedrocan, highlighting that Sativex, which has a marketing authorisation, should be prescribed.